Ingrid C. Rulifson - Concepedia

Concepedia

Author

Ingrid C. Rulifson

Amgen (United States)ORCID

Also Known As

I C Rulifson, I Rulifson, Ingrid C Rulifson, Ingrid C. Rulifson, Ingrid Rulifson

35

Publications

2.4K

Citations

19

H-Index

67

Concepts

All Affiliations

Amgen (United States)May Institute University of California, San Francisco Stanford University University of Chicago

IC

About

Ingrid C. Rulifson is an author at Amgen (United States) specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	1K
2	Health Sciences	3	3	88
3	Natural Sciences	2	2	56
4	Allergy	2	2	193
5	Biochemistry	2	2	56

Ingrid C. Rulifson

×

23

Publications

2.4K

Citations

19

H-Index

	Year	Citations
Growth inhibitors promote differentiation of insulin-producing tissue from embryonic stem cells Yuichi Hori, Ingrid C. Rulifson, Bernette C. Tsai, Proceedings of the National Academy of Sciences	2002	422
Wnt signaling regulates pancreatic β cell proliferation Ingrid C. Rulifson, Satyajit Karnik, Patrick W. Heiser, Proceedings of the National Academy of Sciences Beta Cell ProliferationInsulin SignalingMolecular PhysiologySignal TransductionTissue Development	2007	340
CD28 costimulation promotes the production of Th2 cytokines Ingrid C. Rulifson, Anne I. Sperling, Patrick E. Fields, The Journal of Immunology	1997	293
CD28/B7 interactions deliver a unique signal to naive T cells that regulates cell survival but not early proliferation Anne I. Sperling, Julie Auger, Benjamin D. Ehst, The Journal of Immunology	1996	212
Multiomics study of nonalcoholic fatty liver disease Garðar Sveinbjörnsson, Magnús Ö. Úlfarsson, Rósa B. Þórólfsdóttir, Nature Genetics	2022	211
Cutting edge: blockade of the CD28/B7 costimulatory pathway inhibits intestinal allograft rejection mediated by CD4+ but not CD8+ T cells. Kenneth A. Newell, Gang He, Zhong Guo, PubMed Cell TherapyAdaptive Immune SystemT-regulatory CellImmunologyIntestinal Allograft Rejection	1999	141
Cutting Edge: Blockade of the CD28/B7 Costimulatory Pathway Inhibits Intestinal Allograft Rejection Mediated by CD4+ But Not CD8+ T Cells Kenneth A. Newell, Gang He, Zhong Guo, The Journal of Immunology Cell TherapyAdaptive Immune SystemImmunologyImmune RegulationCd4 T Cell Responses	1999	133
Regulated β-Cell Regeneration in the Adult Mouse Pancreas David A. Cano, Ingrid C. Rulifson, Patrick W. Heiser, Diabetes Lineage PlasticityDevelopmental BiologySignal TransductionSignaling PathwayAdult Mouse Pancreas	2007	100
Expression of HLA-DR4 and human CD4 transgenes in mice determines the variable region beta-chain T-cell repertoire and mediates an HLA-DR-restricted immune response. Lars Fugger, Sara A. Michie, Ingrid C. Rulifson, Proceedings of the National Academy of Sciences HistocompatibilityAdaptive Immune SystemHla ImmunogeneticsImmunologyCd4 T Cell Responses	1994	89
Regulation of C-C chemokine production by murine T cells by CD28/B7 costimulation Kevan C. Herold, Ingrid C. Rulifson, Vaiva Vezys, The Journal of Immunology	1997	85

Page 1